Keros Therapeutics, Inc. (KROS)
NASDAQ·Healthcare·Biotechnology
$11.64
-0.77%
Mkt Cap $358.06M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$20.33
Range $18.00 – $23.00
Implied Upside
+74.7%
Consensus $20.33 vs current $11.64
NASDAQ·Healthcare·Biotechnology
$11.64
-0.77%
Mkt Cap $358.06M
Buy
2
Hold
0
Sell
0
Price Target (10 analysts)
$20.33
Range $18.00 – $23.00
+74.7%
Consensus $20.33 vs current $11.64